ArticleCancer immunology research2016

Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells.

Rebekah L Browning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.